Medtronic Plc (MDT)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

710 MEDTRONIC PKWY MINNEAPOLIS, MN 55432

Medtronic, Inc. (Medtronic) is a medical technology company. The Company is engaged in research, design, manufacture and sale of products to alleviate pain, restore health and extend life. It manufactures and sells device-based medical therapies. It operates in seven segments: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Its primary customers include hospitals, clinics, third party healthcare providers, distributors and other institutions, including governmental healthcare programs and group purchasing organizations.

Data based on most recent fiscal year report
Market Cap106.185 Billion Shares Outstanding1.355 Billion Avg Volume7.954 Million
1-Yr BETA vs S&P TR Current Ratio1.75 Quick Ratio1.51
View SEC Filings from MDT instead.
Q3 2018 All Institutions Hedge Funds 1
To trade MDT now:
Filers who had this stock in their top 10: 66 8 (0.77%)
13F Filers holding this stock: 1447 115 (11.1%)
Aggregate 13F shares on 09/30/2018: 1.087 Billion 66.787 Million
Aggregate 13F shares on 06/30/2018: 1.091 Billion 61.937 Million
Percent change: -0.34% 7.83%
Funds creating new positions: 140 26
Funds Adding to an existing position: 519 44
Funds closing out their position: 58 14
Funds reducing their position: 582 38
Heat Map Ranking for 09/30/2018 27
Heat Map Ranking for 06/30/2018 15
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MDT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

15 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SZYMAN CATHERINE M. CVP, CRITICAL CARE & VASCULAR

  • Officer
29,301 2019-01-15 0

ISHRAK OMAR CHAIRMAN & CEO

  • Officer
  • Director
588,337 2019-01-09 5

PARKHILL KAREN L EVP & CHIEF FINANCIAL OFFICER

  • Officer
83,680 2019-01-09 3

SCHULER JACK W

  • Director
  • 10% Owner
15,993,806 2019-01-08 0

COLLINS ARTHUR D JR

  • Director
45,182 2019-01-03 0

CALHOUN DAVID L

  • Director
0 2019-01-02 0

DONNELLY SCOTT C CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
0 2019-01-02 1

HOGAN RANDALL J

  • Director
444,355 2019-01-02 1

HAWKINS WILLIAM A

  • Director
21,899 2019-01-02 0

POZEN ROBERT C

  • Director
221,066 2018-12-31 3

JACKSON SHIRLEY A

0 2018-12-31 1

LEAVITT MICHAEL O

  • Director
0 2018-12-31 1

HANSON BRYAN C PRESIDENT AND CEO

  • Officer
  • Director
30,115 2018-12-19 0

NABEL ELIZABETH G

  • Director
3,799 2018-12-13 1

OCONNELL CHRISTOPHER J CEO AND PRESIDENT

  • Officer
0 2018-12-10 0

DALLAS H JAMES

  • Director
3,117 2018-12-04 0

WHITE ROBERT JOHN EVP & PRESIDENT MITG

  • Officer
47,590 2018-12-01 5

ELLIS GARY LEE

  • Director
32,513 2018-11-01 0

ARONSON MARTHA GOLDBERG

  • Director
3,000 2018-11-01 0

LIDDICOAT JOHN R EVP & PRESIDENT OF AMERICAS

  • Officer
42,043 2018-10-29 2

MARTHA GEOFFREY EVP & GROUPPRES RESTORA THERAP

  • Officer
59,202 2018-09-24 3

HAKAMI HOOMAN EVP & GROUP PRESIDENT DIABETES

  • Officer
62,647 2018-08-31 5

WARD SCOTT R. CEO AND PRESIDENT

  • Officer
  • Director
278,362 2018-08-29 0

KUNTZ RICHARD SVP & CHIEF MEDICAL & SCIENCE

  • Officer
105,403 2018-08-28 4

MACKIN JAMES P PRESIDENT & CEO

  • Officer
243,298 2018-08-28 0

ANDERSON RICHARD H

  • Director
84,225 2018-08-23 2

COYLE MICHAEL J EVP & GROUP PRES, CARDIAC&VASC

  • Officer
204,534 2018-08-22 3

SURFACE CAROL A SVP, CHIEF HR OFFICER

  • Officer
44,604 2018-08-03 4

LERMAN BRADLEY E SVP GENERAL COUNSEL & CORP SEC

  • Officer
57,653 2018-08-03 3

TEN HOEDT ROB EVP & PRESIDENT EMEA

  • Officer
67,108 2018-08-03 2

FINDLAY D CAMERON SENIOR VICE PRESIDENT

  • Officer
176,322 2018-08-01 0

OESTERLE STEPHEN N.

  • Director
49,360 2018-06-29 0

OLEARY DENISE M

  • Director
88,200 2018-06-13 2

DEMANE MICHAEL F

  • Director
568,855 2018-05-21 0

POWELL KENDALL J

  • Director
33,258 2018-04-30 1

LENEHAN JAMES T

  • Director
48,734 2018-04-30 2

ARNOLD CRAIG

  • Director
29,001 2018-04-30 1

BUTEL JEAN LUC

  • Director
0 2018-02-09 0

STUGE OERN

  • Director
0 2017-05-22 0

REDDY PREETHA

  • Director
7,823 2016-05-02 0

CARLSON TERRANCE L INTERIM GENERAL COUNSEL

  • Officer
2,549 2015-12-11 0

BLANKEMEYER ROBERT H

  • Director
No longer subject to file 2015-10-15 0

DZAU VICTOR J

18,610 2014-06-30 0

MAHLE STEPHEN H

  • Director
No longer subject to file 2014-04-30 0

AYOTTE NEIL P VP INTERIM GEN COUNSEL CORPSEC

12,579 2014-03-10 0

STOCKDALE CAROLINE SR VP HUMAN RESOURCES

44,221 2012-10-29 0

ROSSO JEAN PIERRE

30,654 2012-04-30 0

LANEVE STEPHEN SVP & PRES SPINAL & BIOLOGICS

42,271 2010-04-09 0

ALPERT SUSAN PHD MD SRVP CHIEF REGULATORY

30,336 2009-08-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

PARKHILL KAREN L - Officer EVP & CHIEF FINANCIAL OFFICER

2019-01-09 P 3,000 $83.87 a 83,680 83,680.00 direct

ISHRAK OMAR - Director - Officer CHAIRMAN & CEO

2019-01-09 P 12,000 $84.05 a 570,722 588,337.00 direct

WHITE ROBERT JOHN - Officer EVP & PRESIDENT MITG

2018-12-01 F 1,698 $97.53 d 47,590 47,590.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments